|
|
Previous Article | Table of Contents | Next Article 
A single injection of pegylated murine megakaryocyte growth and development
factor (MGDF) into mice is sufficient to produce a profound stimulation of
megakaryocyte frequency, size, and ploidization
JT Arnold, NC Daw, PE Stenberg, D Jayawardene, DK Srivastava and CW Jackson
Division of Experimental Hematology, St Jude Children's Research Hospital,
Memphis, TN 38105, USA.
Despite numerous studies investigating the action of c-mpl ligand, no
reports have defined the in vivo changes in megakaryocytopoiesis in
response to a single injection of this cytokine. Here we compare the
kinetics of the megakaryocytopoietic response in C57BI/6J mice administered
25 micrograms/ kg or 250 micrograms/kg of pegylated (PEG) murine
megakaryocyte growth and development factor (MGDF) as a single intravenous
injection. Megakaryocytes of mice treated with MGDF had normal
ultrastructure, showing a typical distribution of the demarcation membrane
system, alpha-granules, and other cytoplasmic organelles. Megakaryocyte
ploidy, size, and frequency were markedly increased with both MGDF doses.
Megakaryocyte ploidy was maximally increased from a modal value of 16N to
64N on day 3, with both doses of MGDF. Similarly, a comparable increase in
megakaryocyte size occurred in the two MGDF groups. Increased megakaryocyte
size was coupled to the increase in megakaryocyte ploidy, and no evidence
for independent regulation of megakaryocyte size within individual ploidy
classes was apparent. In contrast to megakaryocyte ploidy and size, the
increase in megakaryocyte frequency was markedly different with the two
doses of MGDF. The proportion of 2N and 4N cells was increased from a
baseline of 0.035% to 0.430% by day 4 in mice treated with the higher dose
of MGDF, but only to 0.175% in mice administered 25 micrograms/kg of MGDF.
The marked increase in the pool of these immature megakaryocytes translated
to a sustained elevation in the frequency of polyploid megakaryocytes (8N
cells and greater). In contrast to the sustained increase in the frequency
of polyploid cells, the level of polyploidization was downregulated on days
6 to 10, but normalized by day 14. We conclude that a single injection of
MGDF is able to expand the megakaryocytic pool in a dose-dependent manner,
which, with subsequent maturation, should lead to an increased rate of
platelet production.
Volume 89,
Issue 3,
pp. 823-833,
02/01/1997
Copyright © 1997 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. Tiedt, J. Coers, S. Ziegler, A. Wiestner, H. Hao-Shen, C. Bornmann, J. Schenkel, S. Karakhanova, F. J. de Sauvage, C. W. Jackson, et al.
Pronounced thrombocytosis in transgenic mice expressing reduced levels of Mpl in platelets and terminally differentiated megakaryocytes
Blood,
February 19, 2009;
113(8):
1768 - 1777.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. McCormack, M. A. Hall, S. M. Schoenwaelder, Q. Zhao, S. Ellis, J. A. Prentice, A. J. Clarke, N. J. Slater, J. M. Salmon, S. P. Jackson, et al.
A critical role for the transcription factor Scl in platelet production during stress thrombopoiesis
Blood,
October 1, 2006;
108(7):
2248 - 2256.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Hall, D. J. Curtis, D. Metcalf, A. G. Elefanty, K. Sourris, L. Robb, J. R. Gothert, S. M. Jane, and C. G. Begley
The critical regulator of embryonic hematopoiesis, SCL, is vital in the adult for megakaryopoiesis, erythropoiesis, and lineage choice in CFU-S12
PNAS,
February 4, 2003;
100(3):
992 - 997.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Kaluzhny, G. Yu, S. Sun, P. A. Toselli, B. Nieswandt, C. W. Jackson, and K. Ravid
BclxL overexpression in megakaryocytes leads to impaired platelet fragmentation
Blood,
August 13, 2002;
100(5):
1670 - 1678.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kirito, M. Osawa, H. Morita, R. Shimizu, M. Yamamoto, A. Oda, H. Fujita, M. Tanaka, K. Nakajima, Y. Miura, et al.
A functional role of Stat3 in in vivo megakaryopoiesis
Blood,
May 1, 2002;
99(9):
3220 - 3227.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Levin, L. Cocault, C. Demerens, C. Challier, M. Pauchard, J. Caen, and M. Souyri
Thrombocytopenic c-mpl{-}/{-} mice can produce a normal level of platelets after administration of 5-fluorouracil: the effect of age on the response
Blood,
August 15, 2001;
98(4):
1019 - 1027.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-M. Luoh, E. Stefanich, G. Solar, H. Steinmetz, T. Lipari, T. I. Pestina, C. W. Jackson, and F. J. de Sauvage
Role of the Distal Half of the c-Mpl Intracellular Domain in Control of Platelet Production by Thrombopoietin In Vivo
Mol. Cell. Biol.,
January 15, 2000;
20(2):
507 - 515.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. Somlo, I. Sniecinski, A. ter Veer, J. Longmate, G. Knutson, S. Vuk-Pavlovic, R. Bhatia, W. Chow, L. Leong, R. Morgan, et al.
Recombinant Human Thrombopoietin in Combination With Granulocyte Colony-Stimulating Factor Enhances Mobilization of Peripheral Blood Progenitor Cells, Increases Peripheral Blood Platelet Concentration, and Accelerates Hematopoietic Recovery Following High-Dose Chemotherapy
Blood,
May 1, 1999;
93(9):
2798 - 2806.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Poujol, D. T.-L. Roux, P. Tropel, V. Roullot, A. Nurden, G. Marguerie, and P. Nurden
Ultrastructural Analysis of Bone Marrow Hematopoiesis in Mice Transgenic for the Thymidine Kinase Gene Driven by the alpha IIb Promoter
Blood,
September 15, 1998;
92(6):
2012 - 2023.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Neelis, T. P. Visser, W. Dimjati, G. R. Thomas, P. J. Fielder, D. Bloedow, D. L. Eaton, and G. Wagemaker
A Single Dose of Thrombopoietin Shortly After Myelosuppressive Total Body Irradiation Prevents Pancytopenia in Mice by Promoting Short-Term Multilineage Spleen-Repopulating Cells at the Transient Expense of Bone Marrow-Repopulating Cells
Blood,
September 1, 1998;
92(5):
1586 - 1597.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. C. Daw, J. T. Arnold, B. A. Abushullaih, P. E. Stenberg, M. M. White, D. Jayawardene, D. Kumar Srivastava, and C. W. Jackson
A Single Intravenous Dose of Murine Megakaryocyte Growth and Development Factor Potently Stimulates Platelet Production, Challenging the Necessity for Daily Administration
Blood,
January 15, 1998;
91(2):
466 - 474.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Shibuya, H. Akahori, K. Takahashi, E. Tahara, T. Kato, and H. Miyazaki
Multilineage Hematopoietic Recovery by a Single Injection of Pegylated Recombinant Human Megakaryocyte Growth and Development Factor in Myelosuppressed Mice
Blood,
January 1, 1998;
91(1):
37 - 45.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Abraham and R. L. Basser
Megakaryocyte Growth and Development Factor: A Review of Early Clinical Studies
Oncologist,
October 1, 1997;
2(5):
311 - 318.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Kimura, A. Hart, M. Hirashima, C. Wang, D. Holmyard, J. Pittman, X.-L. Pang, C. W. Jackson, and A. Bernstein
Zinc Finger Protein, Hzf, Is Required for Megakaryocyte Development and Hemostasis
J. Exp. Med.,
April 1, 2002;
195(7):
941 - 952.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|